The PET-boost trial: isotoxic homogeneous or FDG-directed dose escalation in stage II-III NSCLC
Authors
Cooke, S.De Ruysscher, D
Reymen, B.
Lambrecht, M.
Persson, G. F.
Faivre-Finn, Corinne
Dieleman, E.
Lewensohn, R.
Van Diessen, J.
Sikorska, K.
Lalezari, F.
Sonke, J
Belderbos, J.
Affiliation
netherlands Cancer Institute, Department Of Radiation Oncology, Amsterdam,Issue Date
2020